ClinicalTrials.Veeva

Menu

Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

A

Altamash Institute of Dental Medicine

Status

Not yet enrolling

Conditions

Pulpitis - Irreversible

Treatments

Procedure: Pulp Therapy with Biodentine
Procedure: Pulp Therapy with Mineral trioxide aggregate (MTA)

Study type

Interventional

Funder types

Other

Identifiers

NCT06913283
Altamash IDM Ambreen

Details and patient eligibility

About

The success of pulpotomy treatment is affected by the type of biologically active material used.The effects of MTA and biodentine are compared in mature permanent teeth with caries exposure.It is expected that pulpotomy using biodentine will have a high success rate in caries exposed mature teeth compared to mineral trioxide aggregate.

Enrollment

136 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • mature permanent teeth

Exclusion criteria

  • Teeth with restorations

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

136 participants in 2 patient groups

Group A Mineral trioxide aggregate pulpotomy
Active Comparator group
Treatment:
Procedure: Pulp Therapy with Mineral trioxide aggregate (MTA)
Group B Biodentine pulpotomy
Active Comparator group
Treatment:
Procedure: Pulp Therapy with Biodentine

Trial contacts and locations

1

Loading...

Central trial contact

Dr. Zahid Iqbal; Ambreen Mengal

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems